Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $1.61 million. The enterprise value is $15,466.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SLRX has 2.13 million shares outstanding. The number of shares has increased by 168.54% in one year.
Current Share Class | 2.13M |
Shares Outstanding | 2.13M |
Shares Change (YoY) | +168.54% |
Shares Change (QoQ) | +15.18% |
Owned by Insiders (%) | 1.71% |
Owned by Institutions (%) | 6.66% |
Float | 2.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 26.92 |
P/TBV Ratio | 27.50 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 1.81.
Current Ratio | 1.01 |
Quick Ratio | 0.79 |
Debt / Equity | 1.81 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -300.16% and return on invested capital (ROIC) is -180.23%.
Return on Equity (ROE) | -300.16% |
Return on Assets (ROA) | -98.32% |
Return on Invested Capital (ROIC) | -180.23% |
Return on Capital Employed (ROCE) | -9,183.39% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.79M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.08% in the last 52 weeks. The beta is 0.42, so SLRX's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | -79.08% |
50-Day Moving Average | 0.75 |
200-Day Moving Average | 1.40 |
Relative Strength Index (RSI) | 52.11 |
Average Volume (20 Days) | 24,756 |
Short Selling Information
The latest short interest is 52,652, so 2.48% of the outstanding shares have been sold short.
Short Interest | 52,652 |
Short Previous Month | 84,158 |
Short % of Shares Out | 2.48% |
Short % of Float | 2.52% |
Short Ratio (days to cover) | 1.28 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -5.68M |
Pretax Income | -6.46M |
Net Income | -5.57M |
EBITDA | -5.68M |
EBIT | -5.68M |
Earnings Per Share (EPS) | -$4.47 |
Full Income Statement Balance Sheet
The company has $1.80 million in cash and $112,230 in debt, giving a net cash position of $1.69 million or $0.79 per share.
Cash & Cash Equivalents | 1.80M |
Total Debt | 112,230 |
Net Cash | 1.69M |
Net Cash Per Share | $0.79 |
Equity (Book Value) | 61,866 |
Book Value Per Share | 0.03 |
Working Capital | 27,560 |
Full Balance Sheet Cash Flow
Operating Cash Flow | -4.35M |
Capital Expenditures | n/a |
Free Cash Flow | -4.35M |
FCF Per Share | -$2.05 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |